chr16-3602236-G-A
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBS1_Supporting
The NM_032444.4(SLX4):c.832C>T(p.Arg278Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000143 in 1,614,170 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_032444.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLX4 | NM_032444.4 | c.832C>T | p.Arg278Trp | missense_variant | 4/15 | ENST00000294008.4 | NP_115820.2 | |
SLX4 | XM_024450471.2 | c.832C>T | p.Arg278Trp | missense_variant | 4/15 | XP_024306239.1 | ||
SLX4 | XM_011522715.4 | c.832C>T | p.Arg278Trp | missense_variant | 4/15 | XP_011521017.1 | ||
SLX4 | XR_007064923.1 | n.1481C>T | non_coding_transcript_exon_variant | 4/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLX4 | ENST00000294008.4 | c.832C>T | p.Arg278Trp | missense_variant | 4/15 | 5 | NM_032444.4 | ENSP00000294008 | P1 | |
SLX4 | ENST00000466154.5 | n.1127C>T | non_coding_transcript_exon_variant | 3/7 | 1 | |||||
SLX4 | ENST00000486524.1 | n.1460C>T | non_coding_transcript_exon_variant | 4/4 | 2 | |||||
SLX4 | ENST00000697858.1 | n.173C>T | non_coding_transcript_exon_variant | 2/3 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152206Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000231 AC: 58AN: 251450Hom.: 0 AF XY: 0.000169 AC XY: 23AN XY: 135908
GnomAD4 exome AF: 0.000142 AC: 207AN: 1461846Hom.: 0 Cov.: 31 AF XY: 0.000133 AC XY: 97AN XY: 727216
GnomAD4 genome AF: 0.000158 AC: 24AN: 152324Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74478
ClinVar
Submissions by phenotype
Fanconi anemia Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 19, 2022 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 278 of the SLX4 protein (p.Arg278Trp). This variant is present in population databases (rs141597706, gnomAD 0.08%). This missense change has been observed in individual(s) with cancer (PMID: 23211700, 30306255, 30613976). ClinVar contains an entry for this variant (Variation ID: 456338). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | curation | Sema4, Sema4 | Dec 17, 2021 | - - |
Fanconi anemia complementation group P Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 16, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Nov 18, 2019 | - - |
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden | Nov 03, 2021 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2023 | SLX4: BP4 - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Nov 03, 2022 | Variant summary: BTBD12 (also known as SLX4) c.832C>T (p.Arg278Trp) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00021 in 282844 control chromosomes, predominantly at a frequency of 0.00085 within the Latino subpopulation in the gnomAD database. c.832C>T has been reported in the literature in individuals affected with breast/ovarian cancer and with renal cancer (e.g. de Garibay_2013, Bonache_2018, Lee_2018, Rizzolo_2019). These reports do not provide unequivocal conclusions about association of the variant with Fanconi Anemia. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three ClinVar submitters (evaluation after 2014) cite the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at